“According to a new report published by Introspective Market Research, Intragastric Balloon Market by Product Type, Procedure Type, and End User, The Global Intragastric Balloon Market Size Was Valued at USD 0.062 Billion in 2023 and is Projected to Reach USD 0.147 Billion by 2032, Growing at a CAGR of 10.10%.”

The intragastric balloon market is gaining significant momentum as obesity rates continue to rise globally and demand increases for minimally invasive weight-loss solutions. Intragastric balloons are temporary, non-surgical medical devices placed in the stomach to reduce food intake by inducing a feeling of fullness. These devices are widely used in weight management programs and serve as an effective alternative to bariatric surgery for patients with moderate obesity.

Compared to traditional surgical weight-loss procedures, intragastric balloons offer advantages such as reduced procedural risk, reversibility, shorter recovery times, and lower costs. They are increasingly adopted in hospitals, specialty clinics, and ambulatory surgical centers, particularly among patients seeking non-invasive obesity treatment options.

Advancements in balloon design, improved safety profiles, and growing awareness of obesity-related health risks are further strengthening market growth. As healthcare systems emphasize preventive care and lifestyle management, the intragastric balloon market is expected to witness steady expansion over the forecast period.

Market Segmentation

The Intragastric Balloon Market is segmented into Product Type, Procedure Type, and End User.
By Product Type, the market is categorized into Single Intragastric Balloon, Dual Intragastric Balloon, and Triple Intragastric Balloon.
By Procedure Type, the market is categorized into Endoscopic Placement and Swallowable Balloon Procedure.
By End User, the market is categorized into Hospitals, Specialty Clinics, and Ambulatory Surgical Centers.

Growth Driver

The rising global prevalence of obesity is a major growth driver for the intragastric balloon market. Increasing sedentary lifestyles, unhealthy dietary habits, and growing urbanization have contributed to higher obesity rates across both developed and emerging economies. Obesity is closely associated with chronic conditions such as diabetes, cardiovascular diseases, and hypertension, prompting healthcare providers and patients to seek effective weight-management solutions. Intragastric balloons provide a non-surgical, reversible option that aligns well with patient preferences for minimally invasive treatments, thereby driving market adoption.

Market Opportunity

Technological advancements and increasing acceptance of non-surgical weight-loss treatments present significant opportunities for the intragastric balloon market. Innovations such as swallowable balloons, improved balloon materials, and enhanced safety features are expanding the eligible patient pool. Additionally, rising healthcare investments in emerging markets and growing awareness of obesity management programs create opportunities for manufacturers to expand their global footprint. Strategic collaborations between healthcare providers and device manufacturers are also expected to support market growth during the forecast period.

Detailed Segmentation

Intragastric Balloon Market, Segmentation

The Intragastric Balloon Market is segmented on the basis of Product Type, Procedure Type, and End User.

Product Type

The Product Type segment is further classified into Single Intragastric Balloon, Dual Intragastric Balloon, and Triple Intragastric Balloon. Among these, the Single Intragastric Balloon sub-segment accounted for the highest market share in 2023. This dominance is attributed to its widespread availability, ease of placement, lower cost, and proven clinical effectiveness. Single balloons are commonly preferred in first-time obesity treatments and are supported by extensive clinical data demonstrating safety and consistent weight-loss outcomes.

Procedure Type

The Procedure Type segment is further classified into Endoscopic Placement and Swallowable Balloon Procedure. Among these, the Endoscopic Placement sub-segment accounted for the highest market share in 2023. This is due to its high procedural success rate, physician familiarity, and controlled placement under direct visualization. Endoscopic procedures allow accurate positioning and monitoring, making them a preferred choice in hospitals and specialty clinics despite the emergence of swallowable alternatives.

Some of The Leading/Active Market Players Are-

• Apollo Endosurgery (USA)
• Allurion Technologies (USA)
• ReShape Lifesciences Inc. (USA)
• Spatz Medical (USA)
• Helioscopie Medical Implants (France)
• Silimed (Brazil)
• MEDSIL (Russia)
• Endalis (France)
• Obalon Therapeutics (USA)
• Lexal S.r.l. (Italy)
• Bariatric Solutions GmbH (Germany)
• Medicone (India)
• and other active players.

Key Industry Developments

In March 2023, Allurion Technologies expanded the global availability of its swallowable intragastric balloon system.
The expansion aimed to increase access to non-invasive obesity treatment options and strengthen the company’s presence in emerging healthcare markets by offering simplified, anesthesia-free balloon placement solutions.

In September 2024, Apollo Endosurgery announced advancements in its intragastric balloon product portfolio.
These developments focused on improving patient comfort, safety, and treatment outcomes, reinforcing the company’s leadership position in minimally invasive bariatric devices.

Key Findings of the Study

• Single intragastric balloons dominate the product segment
• Endoscopic placement remains the preferred procedure type
• North America leads the market due to high obesity prevalence
• Rising demand for non-surgical weight-loss solutions is a key driver
• Technological innovation is a major market trend

More Info:- https://introspectivemarketresearch.com/reports/intragastric-balloon-market/

About Us

At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Intragastric Balloon Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global Hormone Replacement Therapy Market industry.

📞 Contact Us
Introspective Market Research Pvt. Ltd.
Phone: +91-91753-37569
Email: sales@introspectivemarketresearch.com
Web: www.introspectivemarketresearch.com